- Home
- About us
About UmanDiagnostics
The company was founded in 2006 and has since then had focus on diseases affecting the white matter such as Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
UmanDiagnostics, a division of Quanterix, supplies NF-Light™ antibodies and ELISA kits, which are widely recognized by researchers and biopharmaceutical and diagnostic companies world-wide as the premier solution for detection of neurofilament light (NF-L) to advance the development of therapeutics and diagnostics.
products
+
years in the business
employees
Our quality policy
UmanDiagnostics is dedicated to the sustainable delivery of high-quality biomarker assays and reagents suitable for their intended purpose.
Quality focus, compliance to applicable regulatory requirements, continuous improvement and customer needs shall underlie all our efforts in development, manufacturing, sales, shipping and customer support.
Sustainable quality is accomplished via maintenance of an effective Quality Management System that includes the following:
- Executive commitment to an environment where quality comes first, continuous improvement and customer satisfaction
- Rigorous management of our product design and development process
- Establishment of appropriate goals throughout the organization to achieve the quality objectives
- Continuous monitoring and improvement of our process metrics, product performance, and quality objectives
- Partnerships with our suppliers and customers for feedback to produce and develop high quality products
- Supporting engagement of our workforce through a culture based on accountability, trust, teamwork and transparency.
UmanDiagnostics quality system has been certified according to ISO 13485 requirements since 2018 and we are delivering product according to the highest quality standards. Bifogar ISO certifikat.